`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`EDWARDS LIFESCIENCES CORPORATION,
`Petitioner,
`
`v.
`
`ENDOHEART AG,
`Patent Owner.
`____________
`
`Case IPR2016-00300
`Patent 8,182,530 B2
`____________
`
`PATENT OWNER’S RESPONSE TO PETITIONER’S MOTION TO
`CORRECT PETITION
`
`37 C.F.R. § 42.104(c)
`
`
`
`
`
`
`
`
`
`IPR2016-00300
`
`Patent Owner respectfully files this response to Petitioner’s motion under 37
`
`C.F.R. § 42.104(c), filed March 22, 2016, to correct an alleged “clerical error” in the
`
`Petition.
`
`I. Authorization For This Paper
`
`In its order dated March 8, 2016, the Board authorized Patent Owner to file
`
`this paper responding to Petitioner’s motion under 37 C.F.R. § 42.104(c). Paper 7.
`
`II. Relationship Between Named Entities
`
`In its motion, Petitioner asserts that “Edwards’ counsel made a clerical error
`
`by inadvertently mis-transcribing that Edwards Lifesciences, LLC is the parent
`
`company of Edwards Lifesciences Corporation.” Mot. at 2 (emphasis
`
`added). Although Patent Owner questions whether Federal Circuit precedent
`
`supports an interpretation of “clerical error” that would excuse a mistake by a
`
`“Senior Attorney” (Ruby J. Natnithithadha) and signed by a “Partner” (W. Todd
`
`Baker), rather than by a paralegal or office clerk1, Patent Owner does not oppose
`
`
`1 Japanese Found. for Cancer Research v. Lee, 773 F.3d 1300, 1307 (Fed. Cir. 2014)
`
`(interpreting the identical phrase “clerical error” in 35 U.S.C. § 255 as “relating to
`
`an office clerk or office work” and “when a subordinate acts contrary to binding
`
`instructions,” and thus denying correction where an erroneous filing was signed by
`
`the “attorney of record” because “it would be impossible for a subordinate who lacks
`
`the duty of exercising judgment to file a valid terminal disclaimer on his own”). Cf.
`
`
`
`2
`
`
`
`IPR2016-00300
`
`entry of the Replacement Petition (Ex. 1043) into the public record. Patent Owner
`
`believes that the public interest is better served by having an accurate and complete
`
`record of Petitioner’s corporate relationships.
`
`III. Failure to Name Edwards Lifesciences PVT
`
`In its motion, Petitioner maintains there are “two real parties-in-interest,”
`
`namely, Edwards Lifesciences Corporation and Edwards Lifesciences LLC. Mot.
`
`at 2 (emphasis added). Petitioner does not allege that its omission of a third real
`
`party-in-interest was a clerical error, nor that the omission should be corrected. (In
`
`its preliminary response, Patent Owner has presented evidence and argument to
`
`satisfy its burden of production that Edwards Lifesciences PVT is an unnamed real
`
`party-in-interest in this proceeding. See Ex. 2008; Ex. 2018-2024; IPR2016-00299
`
`Prelim. Resp. at 51-53.)
`
`Patent Owner opposes any correction of the omission under 37 C.F.R.
`
`Respectfully submitted,
`
`/s/ Edward M. Arons
`Edward M. Arons
`Reg. No. 44,511
`Attorney for Patent Owner
`Endoheart AG
`
`§ 42.104(c).
`
`
`
`
`
`Date: April 5, 2016
`
`
`
`
`
`
`
`37 C.F.R. § 42.6(a)(3) (attorney signature requirements for inter partes reviews).
`
`
`
`3
`
`
`
`IPR2016-00300
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the PATENT OWNER’S
`
`RESPONSE TO PETITIONER’S MOTION TO CORRECT PETITION was
`
`served on the 5th day of April, 2016, via FEDEX EXPRESS ® directed to counsel of
`
`record for the Petitioner: W. Todd Baker (Reg. No. 45,265)
`1940 Duke Street
`Alexandria, Virginia 22314
`Telephone: 703‐412‐6383
`Facsimile: 703‐413‐2220
`
`Oblon, McClelland, Maier and Neustadt, L.L.P.
`
`
`
`
`
`/s/ Edward M. Arons
`Edward M. Arons
`
`
`
`4